Table of Contents
PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of Darunavir tablets to its current portfolio. Darunavir tablets are a human immunodeficiency virus (HIV-1) protease inhibitor indicated for the treatment of HIV-1 infection in adult and pediatric patients 3 years of age and older.
Darunavir 600 mg tablets are available in 60 count bottles.
To find out more about darunavir tablets please visit www.camberpharma.com